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INTRODUCTION
Splenic tumors are relatively rare. There are some
reports on hemangiomas, lymphomas, pseudotu-
mors, angiosarcomas, and metastatic tumors in the
spleen ; however, most tumors are usually found in-
cidentally with no symptoms. There are also some
reports on vascular lesions in the spleen. Some are
hemangiomas with a natural course characterized
by slow growth and basically benign disease ; symp-
toms and their complications usually occur in the
late stage of this disease. In 1940, Kasabach and
Merritt reported a case of an infant with a huge he-
mangioma causing thrombocytopenia-related pur-
ple spots. This huge hemangioma associated with
thrombocytopenia and microangiopathic hemolytic
anemia secondary to consumption coagulopathy was
termed Kasabach-Merritt syndrome (KMS) (1).
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Although most hemangiomas are benign, KMS can
be life-threatening due to complications of thrombo-
cytopenia and coagulopathy. Although there are
many reports of KMS in the liver, there are only a
few reports of KMS with splenic lesions. We experi-
enced a case of a young adult female patient with a
huge splenic vascular lesion, aneurysms of the
splenic artery, and increased plasma levels of fibrin/
fibrinogen degradation products (FDPs) and D-
dimers, demonstrating impending KMS. Consider-
ing her age, we had to ensure a cosmetic outcome.
Therefore, we chose hand-assisted laparoscopic
splenectomy as a minimally invasive surgical treat-
ment. We herein describe this case of a patient with
splenic vascular lesions associated with KMS who
was successfully treated by hand-assisted laparo-
scopic splenectomy.
CASE REPORT
A 35-year-old female patient with no prior medi-
cal history underwent abdominal ultrasonography
as part of a medical checkup. Splenomegaly was
found, and she was transferred to our hospital for
further examination. Computed tomography (CT)
and magnetic resonance imaging (MRI) revealed
splenomegaly (109.0 cm) and a vascular enhanc-
ing splenic mass that had characteristics similar to
those of a hemangioma (Fig. 1). In addition, en-
hanced CT revealed two aneurysms (1.0 and 0.5
cm) in the splenic artery (Fig. 2). She had no ab-
dominal pain or discomfort and was taking no medi-
cation at that time. Laboratory findings revealed a
slightly decreased platelet count (13.0104/μl ; nor-
mal range at our hospital, 15.0-30.0104/μl), in-
creased plasma FDP level (10 μg/ml ; normal,5
μg/ml), and increased D-dimer level (7.9 μg/ml ;
normal, 1.0 μg/ml). Her white blood cell count
was 4500/μl (normal, 4000-9000/μl) and Hb level
was 13.1 g/dl (normal, 11.5-14.5 g/dl). Her hepatic
enzyme levels and ICG15-R were within the normal
ranges.
The patient agreed to undergo surgical treatment
with fully informed consent, and hand-assisted la-
paroscopic splenectomy was planned. Under general
anesthesia, the patient was placed in the right semi-
lateral position. A 7-cm skin incision was made
along the upper midline for a hand-assist port. After
ligation of the splenic artery, the gastrosplenic liga-
ment and gastrocolic ligament were dissected. The
spleen and one aneurysm were removed, and the
other aneurysm was tightly ligated. The operation
time was 188 min, and the total bleeding volume
was 20 ml.
The weight of the resected spleen was 400 g.
Histopathologic examination of the resected spleen
showed widespread chronic congestion and edema-
tous, thickened splenic trabecular walls. In addition,
Fig. 1 : Preoperative CT and MRI images of the splenic vascular
lesions.
CT revealed splenomegaly (109.0 cm) and a vascular enhanc-
ing splenic mass with the characteristics of early enhancement
from the outer edge in the arterial phase and pooling enhance-
ment in the portal phase (upper row). MRI T1- and T2-weighted
images showed a typical hemangioma pattern (T1, isointense ;
T2, marked hyperintensity ; lower row).
Fig. 2 : Preoperative CT angiography of the aneurysms of the
splenic artery.
Enhanced CT revealed two aneurysms (1.0 and 0.5 cm) in the
splenic artery (arrows).
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Gamna-Gandy bodies were seen near the splenic
trabeculae (Fig. 3). There were no malignant cells
in the resected specimen.
Two days after surgical treatment, the platelet
count increased to 18.0104/μl. Moreover, the
plasma D-dimer level decreased to 1.4 μg/ml 3
weeks after the operation, and the plasma FDP level
decreased to 5.0 μg/ml 4 weeks after the operation
(Fig. 4). Enhanced CT as a routine evaluation 1
week after the operation revealed portal vein throm-
bosis ; thus, anticoagulant therapy was started. The
majority of the portal vein thrombosis was dimin-
ished, and the patient was discharged 24 days post-
operatively. At this time, the platelet count was
53.7104/μl.
DISCUSSION
Most splenic vascular lesions are benign and as-
ymptomatic. In previous reports, some splenic vas-
cular lesions, such as hemangiomas associated with
KMS, often required urgent management. KMS is a
rare syndrome mainly occurring in infants with huge
hemangiomas (2). The main pathogenetic mecha-
nism is microvascular consumption coagulopathy
resulting in thrombocytopenia, and the mortality
rate is 30% to 40% among patients with KMS (3). A
large hemangioma could induce activation and con-
sumption of platelets and various coagulation factors,
resulting in a clinical bleeding tendency and local-
ized intravascular coagulation. Bleeding secondary
to consumptive coagulopathy is the primary cause
of death in these patients (4). In the present case,
we tentatively diagnosed “KMS-like phenomenon”
because the patient had a huge vascular lesion in
the spleen with increased plasma FDP and D-dimer
levels. Although there are many reports of KMS
with hemangiomas in the liver and brain (5, 6),
there are no reports on splenic vascular lesions in
adults with no medical history. However, an infant
case of splenic hemangioma associated with KMS
and two adult cases of splenic hemangioma with
Proteus syndrome have been reported (7, 8). There
are also some reports on the nonsurgical treatment
of KMS, such as that involving radiation, corticoster-
oids or interferon alpha-2, embolization, and chemo-
therapy (vincristine) (9). These therapies have both
benefits and disadvantages. Radiation is often admin-
istered at a dose of 15 to 30 Gy in 15 to 22 fractions
over a few weeks with minimal morbidity ; however,
the efficacy of radiation therapy in reversing the dis-
seminated intravascular coagulation associated with
KMS has yet to be determined (10). Although in-
terferon alpha-2 is also known as an anti-angiogenic
drug, a few reports have described its efficacy in the
treatment of vascular malformations and neoplasms
(11). The role of transarterial catheter embolization
in the management of hemangiomas with KMS re-
mains limited due to complications such as vessel re-
canalization and abscess formation (12). Otherwise,
complete tumor resection is usually curative (13).
Moreover, our patient had enlarging aneurysms
in the splenic artery ; we were concerned about the
risk of rupture and thus selected surgical treatment.
Furthermore, Gamna-Gandy bodies were ob-
served near the splenic trabeculae during patho-
logical examination in the present case. These
bodies are considered to reflect chronic congestive
Fig. 3 :Microscopic findings of the splenic vascular lesions
A) Chronic congestion was widely seen in the spleen, and the
walls of the splenic trabeculae were edematous and thickened.
B) Gamna-Gandy bodies were seen near the splenic trabeculae.
This finding was considered to be the reflection of chronic con-
gestive splenomegaly. There were no malignant cells in the re-
sected specimen.
Fig. 4 : Time course of FDP and D-dimer levels
The plasma D-dimer level decreased and normalized after 4
weeks. The plasma FDP level also decreased and normalized after
1 month.
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splenomegaly that results in localized hemorrhage
around the trabeculae of the spleen, hemosiderosis,
and calcifications. They are often found in patients
with portal hypertension, such as that secondary to
splenomegaly, which also fit our patient’s clinical
findings.
We successfully performed hand-assisted laparo-
scopic splenectomy, which was minimally invasive
and cosmetically adequate for this young female
patient. Classical open splenectomy involves an L-
shaped or Benz skin incision that is usually longer
than 20 cm, resulting in pain and disfiguration due
to such a large skin incision. Pure laparoscopic or
hand-assisted laparoscopic splenectomy reportedly
decreases operative blood loss, hospital stay dura-
tion, and patient complaints (14, 15). Therefore,
pure laparoscopic or hand-assisted laparoscopic
splenectomy is considered to be a good choice for
a benign splenic tumor such as that in patients with
KMS, especially for young or female patients. We
herein present a case of a splenic vascular lesion
associated with KMS and splenic arterial aneurysms.
To the best of our knowledge, this is the first re-
port of impending KMS in a patient with splenic vas-
cular lesions with aneurysms. With the progression
of surgical techniques such as laparoscopy, patients
can undergo less invasive treatments. Therefore,
laparoscopic splenectomy can be a first-choice treat-
ment in these cases.
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